Ventyx Biosciences, Inc.

VTYX

Ventyx Biosciences, Inc.

VTYX

Insider Sentiment (TTM):

Last Purchase:2024-12-23Last Sale:2025-12-18Shares Purchased (TTM):0Shares Sold (TTM):60,020

Institutional Sentiment:

As of:2025-12-31Institutional Shares Owned:50,634,675Shares Outstanding:71,304,084Institutional Ownership Pct.:71.01%

Earnings Market Reaction:

Filing Date:2025-11-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Series A Non Voting Preferred Stock	0	0	0	0	0	-	-	0	-	-	-	-
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	32	32	28	27	62	41	142	52	57	52	64	65
Marketable Securities Current	161	177	201	190	213	199	161	201	244	281	313	253
Prepaid Expense And Other Assets	8	10	14	12	15	17	17	12	7	14	10	13
Assets Current	201	219	243	230	289	257	320	264	308	347	387	331
Property Plant And Equipment Net	1	1	1	1	1	1	1	1	1	1	1	0
Operating Lease Right Of Use Asset	9	9	9	10	10	10	10	12	12	1	1	2
Marketable Securities Noncurrent	-	-	-	36	-	40	-	-	-	-	-	39
Restricted Cash Noncurrent	1	1	1	1	1	1	1	1	1	-	-	-
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	211	230	253	277	301	309	332	278	322	349	389	371
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	1	2	3	2	7	6	6	9	4	7	6
Accrued Liabilities Current	9	9	9	9	9	11	8	16	16	16	10	10
Operating Lease Liability Current	1	1	1	1	1	1	1	1	0	0	0	0
Liabilities Current	11	11	12	13	12	18	15	22	26	20	17	16
Operating Lease Liability Noncurrent	9	9	9	10	10	10	11	12	12	1	1	1
Liabilities	20	21	22	23	22	28	25	34	38	21	18	18
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	823	818	813	808	803	771	765	663	657	647	637	581
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	1	-0	-0	-0	-1	-1	-1	-1
Retained Earnings Accumulated Deficit	-632	-609	-582	-554	-525	-490	-458	-419	-372	-318	-265	-226
Stockholders Equity	191	209	232	254	279	281	307	244	284	328	372	354
Liabilities And Stockholders Equity	211	230	253	277	301	309	332	278	322	349	389	371
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	900	900	900	900	900	900	900	900	900	900	900	900
Common Stock Shares Issued	71	71	71	71	71	71	70	59	59	59	58	57
Shares Outstanding	71	71	71	71	71	71	70	59	59	59	58	57

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2025	45.30%	100.00%	171.79%	1.69%	26.27%	146.19%	7.99%	0.00%	51.51%	-	-	-
2024	6.70%	-48.44%	-34.15%	12.63%	16.67%	10.10%	19.64%	6.25%	0.45%	-8.97%	-26.21%	-3.45%
2023	-9.50%	-12.70%	-0.88%	-3.21%	-0.40%	-58.10%	-14.73%	-4.26%	-20.93%	10.74%	-26.12%	-21.82%
2022	-	-	-	-	-	-	-	-	-	-18.24%	-4.41%	-9.04%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Liquidity Ratios
Current Ratio	17.86	19.12	19.57	17.97	23.52	14.19	22.00	11.87	11.76	17.31	23.44	20.21
Quick Ratio	17.86	19.12	19.57	17.97	23.52	14.19	22.00	11.87	11.76	17.31	23.44	20.21
Working Capital	189.84M	207.85M	230.16M	216.85M	277.11M	238.83M	305.23M	242.08M	281.88M	326.67M	370.54M	314.33M
Leverage & Debt
Debt to Equity	0.11	0.10	0.09	0.09	0.08	0.10	0.08	0.14	0.13	0.06	0.05	0.05
Debt Ratio	0.10	0.09	0.09	0.08	0.07	0.09	0.08	0.12	0.12	0.06	0.05	0.05
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-1.50	-1.67	-1.74	-1.97	-2.16	-2.43	-3.12	-3.30	-3.08	-2.70	-2.16	-2.07
Free Cash Flow Per Share TTM	-1.23	-1.49	-1.53	-1.91	-2.26	-2.25	-2.97	-2.85	-2.76	-2.59	-2.03	-1.89
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-30.10%	-30.52%	-35.62%	-29.97%	-15.93%	8.52%	54.55%	77.97%	24.49%	23.28%	-	-
EPS Growth (1Y)	-30.73%	-31.14%	-44.04%	-40.13%	-29.95%	-9.94%	44.07%	59.51%	9.24%	7.05%	-	-
Calculated Values
Free Cash Flow TTM	-87.87M	-105.77M	-109.05M	-131.11M	-159.73M	-158.98M	-183.86M	-167.04M	-162.55M	-151.92M	-117.26M	-99.05M
Net Debt	-31.97M	-32.30M	-28.08M	-27.26M	-61.77M	-40.93M	-141.90M	-51.58M	-56.61M	-51.72M	-63.67M	-64.82M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-18Sale

Owner: Nuss, John

Title: CHIEF SCIENTIFIC OFFICER

Shares: 12,675

Price/Share: $7.72

Value: $97,851.00

Shares Owned: 489,481

Relationship: Officer

Ownership: Direct

2025-12-18Sale

Owner: Mohan, Raju

Title: CEO AND PRESIDENT

Shares: 47,345

Price/Share: $7.72

Value: $365,503.40

Shares Owned: 2,372,863

Relationship: Director,Officer

Ownership: Direct

2025-04-02Sale

Owner: Nuss, John

Title: CHIEF SCIENTIFIC OFFICER

Shares: 1,887

Price/Share: $1.07

Value: $2,019.09

Shares Owned: 467,226

Relationship: Officer

Ownership: Direct

2024-12-27Sale

Owner: Nuss, John

Title: CHIEF SCIENTIFIC OFFICER

Shares: 21,119

Price/Share: $2.36

Value: $49,840.84

Shares Owned: 464,582

Relationship: Officer

Ownership: Direct

2024-12-23Purchase

Owner: Gujrathi, Sheila

Title: -

Shares: 130,000

Price/Share: $2.31

Value: $300,300.00

Shares Owned: 130,000

Relationship: Director

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-12-18	Nuss, John	Officer	CHIEF SCIENTIFIC OFFICER	Direct	Sale	12,675	7.72	$97,851.00	489,481	4
2025-12-18	Mohan, Raju	Director,Officer	CEO AND PRESIDENT	Direct	Sale	47,345	7.72	$365,503.40	2,372,863	4
2025-04-02	Nuss, John	Officer	CHIEF SCIENTIFIC OFFICER	Direct	Sale	1,887	1.07	$2,019.09	467,226	4
2024-12-27	Nuss, John	Officer	CHIEF SCIENTIFIC OFFICER	Direct	Sale	21,119	2.36	$49,840.84	464,582	4
2024-12-23	Gujrathi, Sheila	Director	-	Indirect	Purchase	130,000	2.31	$300,300.00	130,000	4
2024-12-19	Nuss, John	Officer	CHIEF SCIENTIFIC OFFICER	Direct	Sale	13,161	2.26	$29,743.86	485,701	4
2024-11-25	Mohan, Raju	Director,Officer	CEO AND PRESIDENT	Direct	Purchase	261,752	2.01	$526,121.52	2,175,028	4
2024-04-02	Nuss, John	Officer	CHIEF SCIENTIFIC OFFICER	Direct	Sale	1,651	5.40	$8,915.40	264,998	4
2024-04-02	Krueger, Christopher W	Officer	CHIEF BUSINESS OFFICER	Direct	Sale	1,651	5.40	$8,915.40	284,999	4
2024-04-02	Mohan, Raju	Director,Officer	CEO AND PRESIDENT	Direct	Sale	4,312	5.40	$23,284.80	1,578,250	4
2024-04-02	Auster, Martin	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	1,405	5.40	$7,587.00	24,303	4
2023-12-20	Krueger, Christopher W	Officer	Chief Business Officer	Direct	Sale	5,293	2.12	$11,221.16	282,119	4
2023-12-20	Nuss, John	Officer	Chief Scientific Officer	Direct	Sale	17,628	2.12	$37,371.36	262,118	4
2023-12-20	Mohan, Raju	Director,Officer	CEO and President	Direct	Sale	58,860	2.12	$124,783.20	1,570,719	4
2023-10-09	Nsv, Partners Iii Gp Llc,…	TenPercentOwner	-	Indirect	Sale	49,152	30.03	$1,476,034.56	8,439,635	4
2023-10-09	Subramaniam, Somu	Director,TenPercentOwner	-	Indirect	Sale	49,152	30.03	$1,476,034.56	8,439,635	4
2023-10-05	Mohan, Raju	Director,Officer	Chief Executive Officer	Direct	Sale	30,000	29.11	$873,300.00	1,512,911	4
2023-10-03	Krueger, Christopher W	Officer	Chief Business Officer	Direct	Sale	15,000	30.32	$454,800.00	276,548	4
2023-10-03	Nuss, John	Officer	Chief Scientific Officer	Direct	Sale	10,000	30.33	$303,300.00	244,815	4
2023-09-18	Subramaniam, Somu	Director,TenPercentOwner	-	Indirect	Sale	56,665	37.81	$2,142,503.65	8,488,787	4
2023-09-18	Nsv, Partners Iii Lp, Nsv…	TenPercentOwner	-	Indirect	Sale	56,665	37.81	$2,142,503.65	8,488,787	4
2023-09-05	Auster, Martin	Officer	Chief Financial Officer	Direct	Sale	26,472	33.22	$879,399.84	21,177	4
2023-09-05	Krueger, Christopher W	Officer	Chief Business Officer	Direct	Sale	15,000	33.21	$498,150.00	276,548	4
2023-09-05	Mohan, Raju	Director,Officer	Chief Executive Officer	Direct	Sale	30,000	33.21	$996,300.00	1,512,911	4
2023-09-05	Nuss, John	Officer	Chief Scientific Officer	Direct	Sale	10,000	32.83	$328,300.00	244,815	4
2023-08-31	Sandborn, William J.	Officer	See Remarks	Direct	Sale	11,900	33.64	$400,316.00	48,389	4
2023-08-08	Sandborn, William J.	Officer	See Remarks	Indirect	Sale	3,494	32.90	$114,952.60	24,194	4
2023-08-07	Mohan, Raju	Director,Officer	Chief Executive Officer	Direct	Sale	30,000	34.10	$1,023,000.00	1,512,911	4
2023-08-03	Krueger, Christopher W	Officer	Chief Business Officer	Direct	Sale	15,000	35.73	$535,950.00	276,548	4
2023-08-03	Nuss, John	Officer	Chief Scientific Officer	Direct	Sale	10,000	35.74	$357,400.00	244,815	4
2023-07-31	Subramaniam, Somu	Director,TenPercentOwner	-	Indirect	Sale	10,803	37.59	$406,084.77	8,545,452	4
2023-07-31	Nsv, Partners Iii Lp, Nsv…	TenPercentOwner	-	Indirect	Sale	10,803	37.59	$406,084.77	8,545,452	4
2023-07-31	Sandborn, William J.	Officer	See Remarks	Direct	Sale	11,900	37.16	$442,204.00	48,389	4
2023-07-25	Auster, Martin	Officer	Chief Financial Officer	Direct	Sale	28,000	35.54	$995,120.00	47,649	4
2023-07-12	Subramaniam, Somu	Director,TenPercentOwner	-	Indirect	Sale	3,275	37.62	$123,205.50	8,556,866	4
2023-07-12	Nsv, Partners Iii Gp Llc,…	TenPercentOwner	-	Direct	Sale	3,275	37.62	$123,205.50	8,556,866	4
2023-07-07	Nsv, Partners Iii Lp, Nsv…	TenPercentOwner	-	Indirect	Sale	100,000	35.91	$3,591,000.00	9,552,965	4/A
2023-07-07	Subramaniam, Somu	Director,TenPercentOwner	-	Indirect	Sale	100,000	35.91	$3,591,000.00	9,552,965	4/A
2023-07-05	Mohan, Raju	Director,Officer	Chief Executive Officer	Direct	Sale	30,000	39.14	$1,174,200.00	1,512,911	4
2023-07-03	Krueger, Christopher W	Officer	Chief Business Officer	Direct	Sale	15,000	36.75	$551,250.00	276,548	4
2023-07-03	Nsv, Partners Iii Lp, Nsv…	TenPercentOwner	-	Indirect	Sale	134,080	37.74	$5,060,179.20	9,652,965	4
2023-07-03	Subramaniam, Somu	Director,TenPercentOwner	-	Indirect	Sale	134,080	37.74	$5,060,179.20	9,652,965	4
2023-07-03	Nuss, John	Officer	Chief Scientific Officer	Direct	Sale	20,000	36.86	$737,200.00	244,815	4
2023-07-03	Sandborn, William J.	Officer	See Remarks	Direct	Sale	11,900	40.00	$476,000.00	48,389	4
2023-06-23	Sandborn, William J.	Officer	See Remarks	Direct	Sale	10,790	32.48	$350,459.20	48,389	4
2023-06-15	Sandborn, William J.	Officer	See Remarks	Indirect	Sale	3,487	34.32	$119,673.84	31,175	4
2023-06-14	Nsv, Partners Iii Lp, Nsv…	TenPercentOwner	-	Indirect	Sale	50,000	35.08	$1,754,000.00	9,787,045	4
2023-06-14	Subramaniam, Somu	Director,TenPercentOwner	-	Indirect	Sale	50,000	35.08	$1,754,000.00	9,787,045	4
2023-06-07	Subramaniam, Somu	Director,TenPercentOwner	-	Indirect	Sale	35,872	35.79	$1,283,858.88	9,837,045	4
2023-06-07	Nsv, Partners Iii Gp Llc,…	TenPercentOwner	-	Indirect	Sale	35,872	35.79	$1,283,858.88	9,837,045	4
2023-06-06	Auster, Martin	Officer	Chief Financial Officer	Direct	Sale	28,000	34.77	$973,560.00	47,649	4
2023-06-05	Mohan, Raju	Director,Officer	Chief Executive Officer	Direct	Sale	30,000	34.50	$1,035,000.00	1,513,126	4
2023-06-05	Nuss, John	Officer	Chief Scientific Officer	Direct	Sale	10,000	34.47	$344,700.00	244,815	4
2023-06-05	Krueger, Christopher W	Officer	Chief Business Officer	Direct	Sale	15,000	34.48	$517,200.00	276,548	4
2023-05-31	Sandborn, William J.	Officer	See Remarks	Direct	Sale	10,629	34.26	$364,149.54	48,389	4
2023-05-15	Sandborn, William J.	Officer	See Remarks	Indirect	Sale	3,487	36.88	$128,600.56	34,662	4
2023-05-05	Mohan, Raju	Director,Officer	Chief Executive Officer	Direct	Sale	30,000	39.28	$1,178,400.00	1,543,126	4
2023-05-03	Nuss, John	Officer	Chief Scientific Officer	Direct	Sale	10,000	38.57	$385,700.00	244,815	4
2023-05-03	Krueger, Christopher W	Officer	Chief Business Officer	Direct	Sale	15,000	38.56	$578,400.00	276,117	4
2023-04-28	Sandborn, William J.	Officer	See Remarks	Direct	Sale	10,790	36.78	$396,856.20	48,389	4
2023-04-25	Subramaniam, Somu	Director,TenPercentOwner	-	Indirect	Sale	793	38.88	$30,831.84	9,877,045	4
2023-04-25	Nsv, Partners Iii Lp, Nsv…	TenPercentOwner	-	Indirect	Sale	793	38.88	$30,831.84	9,877,045	4
2023-04-25	Auster, Martin	Officer	Chief Financial Officer	Direct	Sale	28,000	38.51	$1,078,280.00	47,649	4
2023-04-17	Auster, Martin	Officer	Chief Financial Officer	Direct	Sale	7,000	33.00	$231,000.00	47,649	4
2023-04-13	Nsv, Partners Iii Lp, Nsv…	TenPercentOwner	-	Indirect	Sale	71,446	30.31	$2,165,528.26	9,977,045	4
2023-04-13	Subramaniam, Somu	Director,TenPercentOwner	-	Indirect	Sale	71,446	30.31	$2,165,528.26	9,977,045	4
2023-04-10	Mohan, Raju	Director,Officer	Chief Executive Officer	Direct	Sale	9,255	29.01	$268,487.55	1,573,126	4
2023-04-06	Mohan, Raju	Director,Officer	Chief Executive Officer	Direct	Sale	7,515	29.01	$218,010.15	1,582,381	4
2023-04-04	Auster, Martin	Officer	Chief Financial Officer	Direct	Sale	21,000	31.06	$652,260.00	47,649	4
2023-04-03	Nuss, John	Officer	Chief Scientific Officer	Direct	Sale	30,000	33.22	$996,600.00	244,815	4
2023-04-03	Krueger, Christopher W	Officer	Chief Business Officer	Direct	Sale	15,000	32.88	$493,200.00	276,117	4/A
2023-03-30	Gujrathi, Sheila	Director	-	Direct	Sale	100,000	33.73	$3,373,000.00	0	4
2023-01-23	White, William Richard	Director	-	Direct	Sale	33,353	35.08	$1,170,023.24	0	4
2022-12-22	Krueger, Christopher W	Officer	Chief Business Officer	Direct	Sale	3,654	31.61	$115,502.94	282,670	4
2022-12-22	Nuss, John	Officer	Chief Scientific Officer	Direct	Sale	13,812	31.61	$436,597.32	244,815	4
2022-12-22	Mohan, Raju	Director,Officer	Chief Executive Officer	Direct	Sale	55,354	31.61	$1,749,739.94	1,603,126	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-12-31

71.01%

Inst. Shares: 50,634,675

Shares Outstanding: 71,304,084

2025-09-30

59.87%

Inst. Shares: 42,686,592

Shares Outstanding: 71,304,084

2025-06-30

60.75%

Inst. Shares: 43,254,991

Shares Outstanding: 71,198,652

2025-03-31

61.26%

Inst. Shares: 43,572,358

Shares Outstanding: 71,131,439

2024-12-31

78.58%

Inst. Shares: 53,811,915

Shares Outstanding: 68,478,172

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-12-31	50,634,675	71,304,084	71.01%
2025-09-30	42,686,592	71,304,084	59.87%
2025-06-30	43,254,991	71,198,652	60.75%
2025-03-31	43,572,358	71,131,439	61.26%
2024-12-31	53,811,915	68,478,172	78.58%
2024-09-30	51,948,622	70,667,570	73.51%
2024-06-30	56,504,417	70,554,718	80.09%
2024-03-31	58,615,586	61,829,976	94.80%
2023-12-31	41,956,086	58,542,974	71.67%
2023-09-30	45,977,214	58,880,427	78.09%
2023-06-30	43,126,418	58,556,529	73.65%
2023-03-31	42,989,071	57,638,923	74.58%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Ventyx Biosciences, Inc. (VTYX) — SEC Financial Statements & Analysis

Ventyx Biosciences, Inc. (VTYX) is a pharmaceutical preparations company, incorporated in DE. Ventyx Biosciences, Inc. trades on Nasdaq as: VTYX. Based on its latest SEC filing (Form 10-Q, period ending 2025-09-30), Ventyx Biosciences, Inc. reported a Debt-to-Equity ratio of 0.11x. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.11x

Data as of 2025-09-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Ventyx Biosciences, Inc. in?

Ventyx Biosciences, Inc. (VTYX) operates in the Pharmaceutical Preparations industry.

What exchange does VTYX trade on?

Ventyx Biosciences, Inc. (VTYX) trades on the Nasdaq.

Where is Ventyx Biosciences, Inc. incorporated?

Ventyx Biosciences, Inc. is incorporated in DE.